A Phase II Study of Panitumumab 5-Fluorouracil and Oxaliplatin in combination with pelvic radiotherapy as treatment of resectable and locally advanced rectal cancer (StarPan Study ヨ STAR 02)

Mise à jour : Il y a 5 ans
Référence : EUCTR2007-001533-34

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To assess the complete pathological response rate over the treatment period when panitumumab, 5-fluorouracil and oxaliplatin are administered in combination with external beam radiotherapy in Subjects with untreated resectable and locally advanced rectal cancer


Critère d'inclusion

  • rectal carcinoma

Liens